Sistema endocanabinoide y desarrollo de esteatosis hepática
The endocannabinoid system (SEC) is an important modulator of several metabolic functions. This system is composed by cannabinoid receptors type 1 and 2 (RCB1 and RCB2), their endogenous ligands, known as endocannabinoids, and the enzymes involved in their synthesis and degradation. A deregulated SE...
Saved in:
| Main Authors: | Valenzuela,Carina, Castillo,Valeska, Ronco,Ana María, Aguirre,Carolina, Hirsch,Sandra, Llanos,Miguel |
|---|---|
| Language: | Spanish / Castilian |
| Published: |
Sociedad Médica de Santiago
2014
|
| Subjects: | |
| Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000300010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Participación del sistema endocanabinoide en el desarrollo de obesidad
by: VALENZUELA,CARINA, et al.
Published: (2010) -
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
by: Kenneth B. Walsh, et al.
Published: (2021) -
Endocannabinoid Metabolism and Traumatic Brain Injury
by: Dexiao Zhu, et al.
Published: (2021) -
Cuantificación de esteatosis hepática no alcohólica por resonancia magnética
by: Herrera,Rodrigo, et al.
Published: (2019) -
LOS ENDOCANABINOIDES: UNA OPCIÓN TERAPÉUTICA PARA EL TRATAMIENTO DEL CÁNCER ENDOCANNABINOIDS: A THERAPEUTIC OPTION TO CANCER TREATMENT
by: Fabio MAYORGA N, et al.
Published: (2009)